CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cashflows from operating activities
Net income (loss)	$ 10,523,871	$ (7,915,516)
Adjustments to reconcile net income (loss) to cashflows from operating activities:
Depreciation, depletion and amortization	18,106,581	9,191,057
Amortization of operating lease asset	46,455	27,767
Asset retirement obligation accretion expense	9,227	7,976
Share-based compensation	328,993	1,290,143
Amortization of deferred financing costs and unpaid interest	1,547,918	187,993
Unrealized loss on derivative instruments	3,077,079	13,815,573
Margin calls on derivative instruments, net	0	(5,342,657)
Changes in operating assets and liabilities	12,901,255	(29,483,694)
Cashflows from (used in) operating activities	46,541,379	(18,221,358)
Cashflows from investing activities
Capital expenditures on oil and natural gas properties	(28,992,460)	(14,778,026)
Cashflows used in investing activities	(28,992,460)	(14,778,026)
Cashflows from financing activities
Proceeds from Redeemable NCI	2,573,145	35,701,365
Redemption and distributions to Redeemable NCI	(3,596,163)	(475,000)
Proceeds from credit facility draws	12,538,462	23,429,339
Credit facility restructuring fees	(78,453)	0
Repayment on credit facility	0	(12,700,000)
Repayment of asset backed preferred notes	0	(3,063,582)
Payment on ABS Facility	(25,342,648)	0
Other long term debt repayment	0	(2,439,231)
Dividends on common shares and noncontrolling interest	(3,438,283)	(4,599,623)
Cash used for common share repurchases	(972,354)	0
Cashflows from (used in) financing activities	(18,316,294)	35,853,268
Net (decrease) increase in cash and cash equivalents and restricted cash	(767,375)	2,853,884
Cash, cash equivalents and restricted cash, beginning of period	10,498,463	8,622,815
Cash, cash equivalents and restricted cash, end of period	$ 9,731,088	$ 11,476,699